Joseph George Verbalis

Joseph George Verbalis's AcademicInfluence.com Rankings

Philosophy

#5480

World Rank

#8294

Historical Rank

Logic

#2750

World Rank

#3785

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Joseph George Verbalis's Degrees

Doctorate Medicine University of Pittsburgh

Why Is Joseph George Verbalis Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Joseph George Verbalis's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. (2006) (1133)
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. (2013) (803)
c-Fos and Related Immediate Early Gene Products as Markers of Activity in Neuroendocrine Systems (1993) (657)
Hyponatremia treatment guidelines 2007: expert panel recommendations. (2007) (446)
Disorders of body water homeostasis. (2003) (381)
Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety. (1986) (362)
Hyponatremia-Induced Osteoporosis (2009) (359)
Oral tolvaptan is safe and effective in chronic hyponatremia. (2010) (317)
Control of brain volume during hyperosmolar and hypoosmolar conditions. (1993) (302)
Oxytocin produces natriuresis in rats at physiological plasma concentrations. (1991) (283)
Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats (1991) (280)
Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats (1991) (243)
Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney. (2000) (239)
Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007 (2008) (235)
Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-Analysis (2013) (235)
Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. (1997) (233)
Interaction of osmotic and volume stimuli in regulation of neurohypophyseal secretion in rats. (1986) (232)
Assessment of the Efficacy and Safety of Intravenous Conivaptan in Euvolemic and Hypervolemic Hyponatremia (2007) (201)
Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. (1991) (195)
Cholecystokinin and gastric distension activate oxytocinergic cells in rat hypothalamus. (1987) (189)
Cholecystokinin Activates C‐Fos Expression in Hypothalamic Oxytocin and Corticotropin‐Releasing Hormone Neurons (1991) (187)
Oxytocin and vasopressin secretion in response to stimuli producing learned taste aversions in rats. (1986) (167)
Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. (2007) (166)
Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015 (2015) (165)
Adaptation to chronic hypoosmolality in rats. (1988) (165)
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. (2011) (162)
c-Fos Expression in Rat Brain and Brainstem Nuclei in Response to Treatments That Alter Food Intake and Gastric Motility (1993) (160)
Responses of Magnocellular Neurons to Osmotic Stimulation Involves Coactivation of Excitatory and Inhibitory Input: An Experimental and Theoretical Analysis (2001) (156)
Medullary c-Fos activation in rats after ingestion of a satiating meal. (1998) (154)
Osteoclast Response to Low Extracellular Sodium and the Mechanism of Hyponatremia-induced Bone Loss* (2010) (153)
Evaluation and management of hypo-osmolality in hospitalized patients. (2003) (151)
Consensus Statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005 (2005) (149)
Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex (1992) (142)
Brain volume regulation in response to changes in osmolality (2010) (142)
Rosiglitazone Activates Renal Sodium- and Water-Reabsorptive Pathways and Lowers Blood Pressure in Normal Rats (2004) (136)
Cost of illness of hyponatremia in the United States (2006) (135)
Vasopressin receptor antagonists. (2001) (134)
Vasopressin V2 receptor antagonists. (2001) (133)
Current treatment practice and outcomes. Report of the hyponatremia registry (2015) (133)
Central inhibitory control of sodium appetite in rats: correlation with pituitary oxytocin secretion. (1987) (120)
Neurological and neuropathological sequelae of correction of chronic hyponatremia. (1991) (119)
Updated fluid recommendation: position statement from the International Marathon Medical Directors Association (IMMDA). (2006) (117)
LiCl and CCK inhibit gastric emptying and feeding and stimulate OT secretion in rats. (1989) (105)
Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality. (2005) (104)
Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise. (2008) (102)
Central oxytocin and ANP receptors mediate osmotic inhibition of salt appetite in rats. (1995) (102)
Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans. (1989) (101)
Hyponatremia Improvement Is Associated with a Reduced Risk of Mortality: Evidence from a Meta-Analysis (2015) (100)
Hyponatremia Is Associated With Increased Osteoporosis and Bone Fractures in a Large US Health System Population. (2015) (100)
Central oxytocin inhibition of angiotensin-induced salt appetite in rats. (1992) (99)
Age-associated abnormalities of water homeostasis. (2013) (98)
Central inhibition of salt appetite by oxytocin in rats (1996) (96)
Acute changes in endocrine and fluid balance markers during high-intensity, steady-state, and prolonged endurance running: unexpected increases in oxytocin and brain natriuretic peptide during exercise. (2008) (96)
Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation. (2003) (95)
Central c-Fos expression in neonatal and adult rats after subcutaneous injection of hypertonic saline (1997) (95)
Vasopressin release in response to nausea-producing agents and cholecystokinin in monkeys. (1987) (95)
Acute endotoxemia in rats induces down-regulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla. (2004) (93)
Increased renal Na-K-ATPase, NCC, and β-ENaC abundance in obese Zucker rats (2001) (92)
Establishing behavioral and physiological functions of central oxytocin: insights from studies of oxytocin and ingestive behaviors. (1995) (91)
Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage (1992) (89)
Central oxytocin inhibition of salt appetite in rats: evidence for differential sensing of plasma sodium and osmolality. (1993) (87)
Impaired secretion of vasopressin and oxytocin in rats after lesions of nucleus medianus. (1985) (87)
Central oxytocin inhibition of food and salt ingestion: a mechanism for intake regulation of solute homeostasis (1993) (87)
Whole-body volume regulation and escape from antidiuresis. (2006) (86)
Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. (1988) (85)
Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats (1993) (84)
Sodium appetite in rats after prolonged dietary sodium deprivation: a sexually dimorphic phenomenon. (1991) (83)
Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats (2013) (82)
Gastric motility in consious rats given oxytocin and an oxytocin antagonist centrally (1992) (81)
Statement of the 3rd International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015 (2015) (81)
Vasopressin V2 receptor antagonists. (2002) (80)
Cold water stimulation of oropharyngeal receptors in man inhibits release of vasopressin. (1987) (80)
Brain oxytocin receptors mediate corticotropin-releasing hormone-induced anorexia. (1991) (78)
Sex differences in vasopressin V₂ receptor expression and vasopressin-induced antidiuresis. (2011) (78)
Diabetes insipidus as a complication after pituitary surgery (2007) (78)
Dysregulation of renal salt and water transport proteins in diabetic Zucker rats. (2002) (77)
Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion. (2016) (77)
Hyponatremia in rats induces downregulation of vasopressin synthesis. (1990) (76)
Osmotic regulation of plasma vasopressin and oxytocin after sustained hyponatremia. (1986) (68)
Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure. (1985) (68)
Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy. (1987) (67)
Vasopressin V2 Receptor Binding Is Down-Regulated during Renal Escape from Vasopressin-Induced Antidiuresis1. (2000) (67)
Blood–Brain Barrier Disruption and Complement Activation in the Brain Following Rapid Correction of Chronic Hyponatremia (2000) (65)
A reevaluation of the effects of stimulation of the dorsal motor nucleus of the vagus on gastric motility in the rat. (2007) (65)
Increased abundance of distal sodium transporters in rat kidney during vasopressin escape. (2001) (65)
Lithium chloride-induced anorexia, but not conditioned taste aversions, in rats with area postrema lesions (1994) (63)
Increased renal ENaC subunit and sodium transporter abundances in streptozotocin-induced type 1 diabetes. (2003) (63)
Use of steroid profiles in determining the cause of adrenal insufficiency (2007) (62)
Disorders of water and salt metabolism associated with pituitary disease. (2008) (61)
Disorders of body water homeostasis in critical illness. (2006) (60)
An experimental model of syndrome of inappropriate antidiuretic hormone secretion in the rat. (1984) (59)
Capsaicin pretreatment attenuates multiple responses to cholecystokinin in rats. (1988) (59)
Pathogenesis of hyponatremia in an experimental model of the syndrome of inappropriate antidiuresis. (1994) (59)
How does the brain sense osmolality? (2007) (59)
Hormones and behavior: the biology of thirst and sodium appetite (1988) (57)
Postoperative and Post-Traumatic Diabetes insipidus (1985) (57)
Central oxytocin mediates inhibition of sodium appetite by naloxone in hypovolemic rats. (1992) (57)
MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response. (1985) (57)
AVP receptor antagonists as aquaretics: review and assessment of clinical data. (2006) (56)
Exogenous cholecystokinin activates cFos expression in medullary but not hypothalamic neurons in neonatal rats. (1994) (56)
Systemic diseases associated with disorders of water homeostasis. (2002) (55)
Escape from vasopressin-induced antidiuresis: role of vasopressin resistance of the collecting duct. (1998) (54)
GABA signaling in the nucleus tractus solitarius sets the level of activity in dorsal motor nucleus of the vagus cholinergic neurons in the vagovagal circuit. (2009) (53)
Changes in Copeptin and Bioactive Vasopressin in Runners With and Without Hyponatremia (2011) (53)
Gastric motility and food intake in rats after lesions of hypothalamic paraventricular nucleus. (1992) (51)
Sodium status of collapsed marathon runners. (2005) (50)
Hyponatremia: epidemiology, pathophysiology, and therapy. (1993) (49)
Neurohypophyseal secretion in hypovolemic rats: inverse relation to sodium appetite. (1987) (49)
CNS Site of Action and Brainstem Circuitry Responsible for the Intravenous Effects of Nicotine on Gastric Tone (2002) (48)
Osmotic Inhibition of Neurohypophysial Secretion (1993) (48)
Increased blood pressure, aldosterone activity, and regional differences in renal ENaC protein during vasopressin escape. (2004) (48)
Short‐ and long‐term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2‐receptor antagonist: the DILIPO study (2011) (47)
Downregulation of renal vasopressin V2 receptor and aquaporin-2 expression parallels age-associated defects in urine concentration. (2004) (46)
The Brain Oxytocin Receptor(s?) (1999) (46)
Area postrema lesions in rats appear to disrupt rapid feedback inhibition of fluid intake (1996) (46)
Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. (2019) (46)
Impaired osmoregulatory responses in rats with area postrema lesions. (1999) (45)
Vasopressin and oxytocin secretion in chronically hyposmolar rats. (1991) (45)
Sodium Homeostasis and Bone (2014) (45)
Naloxone potentiation of effects of cholecystokinin and lithium chloride on oxytocin secretion, gastric motility and feeding. (1988) (45)
Oxytocin is elevated in plasma of 10-day-old rats following gastric distension. (1998) (44)
Effect of rapid correction of hyponatremia on the blood-brain barrier of rats (1995) (41)
Effects of anorexigenic treatments on gastric motility in rats. (1989) (41)
Caloric and noncaloric controls of food intake (1991) (41)
Novel Vasopressin V1A and V2 Antagonist (Conivaptan) Increases Serum Sodium Concentration and Effective Water Clearance in Patients with Hyponatremia (2004) (41)
Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis. (2000) (41)
Increased renal Na-K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats. (2001) (40)
Disorders of Water Balance (2012) (40)
Selective Gene Expression in Magnocellular Neurons in Rat Supraoptic Nucleus (2004) (40)
Adaptation to acute and chronic hyponatremia: implications for symptomatology, diagnosis, and therapy. (1998) (40)
Control of appetite and satiety: insights from biologic and behavioral studies. (2009) (37)
Acute changes in arginine vasopressin, sweat, urine and serum sodium concentrations in exercising humans: does a coordinated homeostatic relationship exist? (2008) (37)
Adaptive responses to sustained volume expansion in hyponatraemic rats. (1989) (36)
Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases (2013) (36)
Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia (2014) (36)
Changes in plasma arginine vasopressin concentrations in cyclists participating in a 109-km cycle race (2008) (35)
Management of Disorders of Water Metabolism in Patients with Pituitary Tumors (2004) (35)
Renal ENaC subunit, Na-K-2Cl and Na-Cl cotransporter abundances in aged, water-restricted F344 x Brown Norway rats. (2006) (35)
Dorsal motor nucleus of the vagus: a site for evoking simultaneous changes in crural diaphragm activity, lower esophageal sphincter pressure, and fundus tone. (2008) (35)
Reversible panhypopituitarism caused by a suprasellar aneurysm: the contribution of mass effect to pituitary dysfunction. (1982) (34)
Renal Function and Vasopressin During Marathon Running (2007) (34)
Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT). (2016) (34)
c-Fos and Fos-related antigens as markers for neuronal activity: perspectives from neuroendocrine systems. (1993) (34)
Dysnatremia Predicts a Delayed Recovery in Collapsed Ultramarathon Runners (2007) (34)
Pathophysiology of Water Metabolism During Critical Illness (1997) (33)
Gene expression in the rat supraoptic nucleus induced by chronic hyperosmolality versus hyposmolality. (2000) (33)
Evaluation of maternal fluid dynamics during tocolytic therapy with ritodrine hydrochloride and magnesium sulfate. (1992) (33)
Hyponatremia induced by vasopressin or desmopressin in female and male rats. (1993) (32)
Regulation of gene expression in magnocellular neurons in rat supraoptic nucleus during sustained hypoosmolality. (2005) (32)
Glucose acts in the CNS to regulate gastric motility during hypoglycemia. (2003) (31)
Functional neurolobectomy induced by controlled compression of the pituitary stalk (1992) (31)
Syndrome of inappropriate antidiuresis in the absence of arginine vasopressin. (1986) (31)
Water intake and body fluids (1999) (30)
Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study (2017) (30)
Lipopolysaccharide Endotoxin Potentiates the Effect of Osmotic Stimulation on Vasopressin Synthesis and Secretion in the Rat Hypothalamus (2003) (30)
Catecholamine, Renin, Aldosterone, and Arginine Vasopressin Responses to Lower Body Negative Pressure and Tilt in Normal Humans: Effects of Bromocriptine (1985) (30)
Quantitation of changes in the content of neurohypophyseal peptides in hypothalamic nuclei after adrenalectomy. (1983) (30)
Efficacy of oral versus intravenous hypertonic saline in runners with hyponatremia. (2014) (29)
micro-Opioid receptor stimulation in the medial subnucleus of the tractus solitarius inhibits gastric tone and motility by reducing local GABA activity. (2010) (29)
Hyponatremia in Neurotrauma: The Role of Vasopressin. (2016) (28)
Hypertonic NaCl inhibits gastric motility and food intake in rats with lesions in the rostral AV3V region. (1992) (28)
Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure. (1986) (28)
Fluid intake and homeostasis (1999) (28)
Inhibitory effects of estrogen on stimulated salt appetite in rats. (1994) (27)
Conivaptan: Evidence supporting its therapeutic use in hyponatremia (2009) (27)
Control of brain volume during hypoosmolality and hyperosmolality. (2006) (27)
Positive association between blood brain barrier disruption and osmotically-induced demyelination (2000) (27)
Synergistic effects of nitric oxide and prostaglandins on renal escape from vasopressin-induced antidiuresis. (2003) (26)
Differential Kinetics of Oxytocin and Vasopressin Heteronuclear RNA Expression in the Rat Supraoptic Nucleus in Response to Chronic Salt Loading In vivo (2007) (26)
Kidney aquaporin-2 expression during escape from antidiuresis is not related to plasma or tissue osmolality. (1999) (26)
Escape from vasopressin-induced antidiuresis: role of vasopressin resistance of the collecting duct. (1998) (26)
Microarray Analysis of Gene Expression in the Supraoptic Nucleus of Normoosmotic and Hypoosmotic Rats (2006) (26)
Studies of renal aquaporin-2 expression during renal escape from vasopressin-induced antidiuresis. (1998) (25)
Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney. (2005) (25)
Characterization of noradrenergic transmission at the dorsal motor nucleus of the vagus involved in reflex control of fundus tone. (2008) (25)
The effect of chronic mild hyponatremia on bone mineral loss evaluated by retrospective national Danish patient data. (2016) (24)
Melanocortin Signaling in the Brainstem Influences Vagal Outflow to the Stomach (2013) (24)
Administration of dehydroepiandrosterone (DHEA) increases serum levels of androgens and estrogens but does not enhance short-term memory in post-menopausal women (2012) (24)
Increased renal alpha-ENaC and NCC abundance and elevated blood pressure are independent of hyperaldosteronism in vasopressin escape. (2006) (23)
Diagnostic Testing for Diabetes Insipidus (2019) (23)
Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study (2017) (22)
Models of Interinstitutional Partnerships between Research Intensive Universities and Minority Serving Institutions (MSI) across the Clinical Translational Science Award (CTSA) Consortium (2013) (22)
In vitro release of vasopressin and oxytocin from rat median eminence tissue. (1986) (21)
Hindbrain chemical mediators of reflex-induced inhibition of gastric tone produced by esophageal distension and intravenous nicotine. (2005) (21)
Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia (2016) (20)
Sex and the basic scientist: is it time to embrace Title IX? (2013) (20)
Effects of glucoprivation on gastric motility and pituitary oxytocin secretion in rats. (1990) (19)
Carotid artery aneurysm simulating pituitary adenoma. (1982) (19)
Inhibition of salt appetite in rats by central oxytocin. (2004) (18)
Low Plasma Oxytocin Levels and Increased Psychopathology in Hypopituitary Men With Diabetes Insipidus. (2019) (18)
Sodium deprivation blunts hypovolemia-induced pituitary secretion of vasopressin and oxytocin in rats. (1994) (18)
Hyponatremia with intracranial disease: not often cerebral salt wasting. (2014) (18)
Glucose does not activate nonadrenergic, noncholinergic inhibitory neurons in the rat stomach. (2005) (18)
Hypothalamic Pituitary Adrenal Axis and Hypothalamic–Neurohypophyseal Responsiveness in Water-Deprived Rats (2001) (18)
Sodium appetite in lactating rats. (1990) (17)
Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women. (2011) (17)
Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion. (2010) (17)
Effect of protein intake and urea on sodium excretion during inappropriate antidiuresis in rats. (1988) (17)
Abnormalities of water homeostasis in aging. (2005) (17)
Subdiaphragmatic Vagotomy With Pyloroplasty Ameliorates the Obesity Caused by Genetic Deletion of the Melanocortin 4 Receptor in the Mouse (2018) (17)
Hyponatraemia and the Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Drug Therapy in Psychiatric Patients (1995) (16)
Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. (1990) (16)
Hyponatremia endocrinologic causes and consequences of therapy (1992) (16)
Role of thromboxane receptors in the dipsogenic response to central angiotensin II. (2002) (16)
Changes in Cerebral Blood Flow and Distribution Associated with Acute Increases in Plasma Sodium and Osmolality of Chronic Hyponatremic Rats (2000) (16)
The effect of the maze procedure on the secretion of arginine-vasopressin and aldosterone. (2003) (16)
Regulation of renal salt and water transporters during vasopressin escape. (2002) (16)
Acquired forms of central diabetes insipidus: Mechanisms of disease. (2020) (16)
Renal physiology of nocturia (2014) (15)
Acute effects of ethanol on ingestive behavior in rats. (1994) (15)
Clinical Aspects of Body Fluid Homeostasis in Humans (1990) (14)
Identification of high molecular weight neurophysins in extracts of human neurohypophyseal tissue (1982) (14)
Preparedness of the CTSA's Structural and Scientific Assets to Support the Mission of the National Center for Advancing Translational Sciences (NCATS) (2012) (14)
Estradiol Attenuates Angiotensin-Induced Aldosterone Secretion in Ovariectomized Rats* *This work was supported by NIH Grants HL-57502 (to K.S.), AG-16902 (to K.S.), and DK-38094 (to J.G.V.). (2000) (14)
Chronic hypoosmolality induces a selective decrease in magnocellular neurone soma and nuclear size in the rat hypothalamic supraoptic nucleus. (2001) (14)
Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion. (2010) (14)
Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise. (2014) (14)
The Need for Salt: Does a Relationship Exist Between Cystic Fibrosis and Exercise-Associated Hyponatremia? (2014) (13)
Characterization of neurophysin-vasopressin prohormones in human posterior pituitary tissue. (1983) (13)
Inhibitory Controls of Drinking: Satiation of Thirst (1991) (13)
Dehydration anorexia in decerebrate rats. (1995) (12)
Disorders of water metabolism: diabetes insipidus and the syndrome of inappropriate antidiuretic hormone secretion. (2014) (12)
Hyponatremia and Hypo-osmolar Disorders (2009) (11)
Impaired osmoregulatory responses in rats with area postrema lesions. (1999) (11)
Isolation and localization of neurophysin-like proteins in rat uterus (1985) (11)
CHAPTER 10 – Posterior Pituitary (2011) (11)
Generation and Characterization of an Antiserum Directed Against Neurohypophyseal Prohormones (1991) (11)
Role of AVP in pressor responses during activation of central TxA2/PGH2receptors. (1997) (11)
Biological Bases of Hunger and Satiety (1987) (11)
RECEPTOR ANTAGONISTS Vasopressin V 2 receptor antagonists (2002) (11)
Increased urinary excretion of PGE2 during inappropriate antidiuresis induced by DDAVP. (1986) (10)
The Curious Story of Cerebral Salt Wasting: Fact or Fiction? (2020) (10)
Heterogeneity of human pituitary neurophysins by ampholyte displacement chromatography. (1983) (9)
Species-specific effects of bombesin on gastric emptying and neurohypophyseal secretion (1988) (9)
Euvolemic Hyponatremia Secondary to the Syndrome of Inappropriate Antidiuresis. (2019) (9)
Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus. (2005) (9)
Design of a prospective, multinational registry to evaluate patients hospitalized with hyponatremia: the HN Registry (2013) (9)
The treatment of severe hyponatremia. (1998) (9)
Advances in human oxytocin measurement: challenges and proposed solutions (2022) (9)
Escape from antidiuresis: a good story. (2001) (9)
THE EFFECTS OF HYPONATREMIA ON BONE DENSITY AND FRACTURES: A SYSTEMATIC REVIEW AND META-ANALYSIS. (2019) (8)
Use of Immediate early genes as markers of oxytocin and vasopressin neuronal activation (1995) (8)
Isolated adrenocorticotrophic hormone deficiency presenting as chronic hyponatremia. (1990) (8)
Tumoral hyponatremia. (1986) (8)
Ten Essential Points about Body Water Homeostasis (2007) (8)
The vagus plays a role in the anti-reflux barrier by controlling both the lower esophageal sphincter pressure and crural diaphragm activity (2005) (8)
Effect of suckling on gastric motility in lactating rats. (1991) (8)
CONIVAPTAN FOR THE TREATMENT OF HYPONATREMIA IN HOSPITALIZED PATIENTS: RESULTS FROM AN OPEN-LABEL STUDY.: 242 (2006) (8)
CONIVAPTAN, A NOVEL ARGININE VASOPRESSIN ANTAGONIST, PRODUCED AQUARESIS AND INCREASED SERUM SODIUM CONCENTRATION IN PATIENTS WITH EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA.: 234-T (2005) (8)
Differential effects of atrial natriuretic peptide infusion at physiological doses in different postures in humans. (1991) (7)
Role of AVP in pressor responses during activation of central TxA2/PGH2 receptors. (1997) (7)
Presumed infundibuloneurohypophysitis: unusual presentation in a postpartum patient. (2005) (7)
Sex and basic science. A Title IX position. (2014) (7)
Effect of acute and chronic hyponatremia on brain buffering in rats. (1993) (7)
Hyponatremia and the risk of kidney stones: A matched case-control study in a large U.S. health system (2018) (6)
Recent advances in neurohypophyseal research. (1981) (6)
Water and Salt Intake and Body Fluid Homeostasis (2013) (6)
Gonadal hormone regulation of the renal vasopressin V2 receptor (2008) (6)
Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study (2016) (6)
Changes in steroid concentrations with the timing of corticotropin stimulation testing in participants with adrenal sufficiency. (2012) (6)
Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (5)
OR32-05 Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men (2020) (5)
Hyponatremia Is Linked to Bone Loss, Osteoporosis, Fragility and Bone Fractures. (2019) (5)
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. (2022) (5)
7 – Hyponatremia and Hypoosmolar Disorders (2014) (5)
Disorders of water and sodium homeostasis and bone (2018) (5)
Correction: Hyponatremia Improvement Is Associated with a Reduced Risk of Mortality: Evidence from a Meta-Analysis (2016) (5)
Aging-related impairment of urine-concentrating mechanisms correlates with dysregulation of adrenocortical angiotensin type 1 receptors in male Fischer rats. (2016) (4)
Hyponatremia: answered and unanswered questions. (1991) (4)
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. (2022) (4)
Rat model for investigating ACTH-independent angiotensin-induced aldosterone secretion (2000) (4)
Treatment of Central Diabetes insipidus1 (1985) (4)
Overlap between nocturnal polyuria, diurnal polyuria, and 24-h polyuria among men with nocturia (2020) (3)
Challenges in assessing the impact of hyponatremia management on length of stay: Interim results from a global, multi-center, prospective, observational registry of hospitalized hypervolemic and euvolemic hyponatremic patients (2013) (3)
LBMON62 Central Diabetes Insipidus From A Patients’ Perspective- From Management To Psychological Co-morbidities And Re-naming Of The Condition (2022) (3)
Diagnosing Nocturnal Polyuria from a Single Nocturnal Urine Sample. (2020) (3)
Brain buffering is restored in hyponatremic rats by correcting their plasma sodium concentration. (1994) (3)
CALL FOR PAPERS Neurohypophyseal Hormones: From Genomics and Physiology to Disease Increased renal -ENaC and NCC abundance and elevated blood pressure are independent of hyperaldosteronism in vasopressin escape (2006) (3)
Neuroendocrine Regulation of Fluid Intake and Homeostasis (2000) (3)
The use of an algorithm to aid diagnosis and treatment of patients with hyponatraemia secondary to SIADH (2010) (3)
Hyponatremia inhibits sprouting of oxytocinergic axons following bilateral lesions of the paraventricular nucleus in rats (1994) (2)
Efficacy and safety of the vasopressin antagonist conivaptan in patients with euvolemic hyponatremia evaluated in a phase III clinical trial. (2006) (2)
Disorders of Water Metabolism (2017) (2)
Escape from Vasopressin-Induced Antidiuresis: Insights at the Molecular Level. (1999) (2)
Identifying men with global polyuria on a nocturnal‐only voiding diary (2020) (2)
Oxytocin infused intracerebroventricularly inhibits food intake in rats (1989) (2)
Human pituitary neurophysin precursors. (1983) (2)
Hyponatraemia in the hospital setting: interim results from a prospective, observational, multicentre, global registry (2012) (2)
Sex differences in the renal and cardiovascular responses to aldosterone: role of nitric oxide (2006) (2)
Biosynthesis Transport and Release of Vasopressin1 (1985) (2)
Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men. (1992) (2)
An Antifungal for Antidiuresis? (2019) (2)
Acid-base / electrolytes / nephrolithiasis (2013) (2)
Glucose Does Not Activate Non-Adrenergic , Non-Cholinergic ( NANC ) Inhibitory Neurons in the Rat Stomach (2004) (2)
Effects of osmotic dehydration on food intake, gastric motility and oxytocin secretion in rats (1989) (2)
Development of an experimental model to study the pathophysiology of cerebral salt wasting following subarachnoid hemorrhage. (2012) (2)
PSY37 IMPACT OF TOLVAPTAN ON SELF-REPORTED UTILITY SCORES IN HYPONATREMIC PATIENTS (2009) (2)
49 – Vasopressin Receptors (2009) (2)
40PD SMALL CELL LUNG CANCER AND HYPONATREMIA: INTERIM RESULTS FROM A PROSPECTIVE, OBSERVATIONAL, GLOBAL REGISTRY (2013) (2)
Oxytocin Levels in Response to Pituitary Provocation Tests in Healthy Volunteers (2021) (2)
Commentary: Evidence-based Medicine for SIAD. (2020) (2)
Translational control in regulation of the renin-angiotensin system (2000) (2)
EFFICACY AND SAFETY OF CONIVAPTAN, A VASOPRESSIN V1A- AND V2-RECEPTOR ANTAGONIST, DURING PHASE 3 TRIALS OF PATIENTS WITH EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA (2007) (1)
Comments on: "Esophageal-gastric relaxation reflex in rat: dual control of peripheral nitrergic and cholinergic transmission". (2006) (1)
Cancer-Related Hyponatremia: Enhancing Recognition and Improving Management. (2016) (1)
Moderate hyponatremia is associated with an increased risk of overall mortality: a comprehensive meta-analysis (2013) (1)
Medullary c-Fos activation in rats after ingestion of a satiating meal. (1998) (1)
Hypogonadal Male Runners Do Not Display Endocrine or Performance Decrements during Prolonged Endurance Exercise (2009) (1)
Metabolic, renal, and cardiovascular effects of selective estrogen receptor agonists (2006) (1)
Acknowledgement of reviewers 2011 (2012) (1)
Hyponatremia in Marathon Runners due to Inappropriate (2007) (1)
Changing the name of diabetes insipidus (2022) (1)
Sex and the basic scientist: is it time to embrace Title IX? (2013) (1)
Diabetes Insipidus: Principles of Diagnosis and Treatment (2016) (1)
Management of euvolemic hyponatremia attributed to SIADH in the hospital: interim results from a prospective, observational, multi-center, global registry (2013) (1)
Endocrinologic Causes and Consequences of Therapy (1992) (1)
Central Control of Fluid and Electrolyte Homeostasis Characterization of the effects of the vasopressin V 2 receptor on sweating , fluid balance , and performance during exercise (2014) (1)
Posterior Pituitary: Disorders of Water Metabolism (2002) (1)
Future of Hyponatremia Research. (2019) (1)
Hyponatremia Is Associated With Increased Osteoporosis and Bone Fractures in Patients With Diabetes With Matched Glycemic Control (2019) (1)
330: Low Frequency of Overly Rapid Serum Sodium Correction During Treatment of Euvolemic or Hypervolemic Hyponatremia With Conivaptan (2007) (1)
PowerPoint Slides for: Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study (2017) (1)
Chapter 201 – Neurohypophyseal Peptides (2013) (1)
Hyponatremia in the Hospital Setting: Interim Results from a Prospective, Observational, Multi-Center, Global Registry (2013) (1)
Neuroendocrine Regulation of Body Water and Electrolytes: Thirst and Salt Appetite (2012) (1)
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus (2022) (1)
First voided volume: A novel approach to characterize nocturia (2021) (1)
Central oxytocin receptor antagonism potentiates angiotensin-induced salt appetite in rats (1992) (1)
Figure 2: [Graphical representation of the water deprivation test. Image courtesy: Sriram Gubbi, NIDDK, NIH]. (2019) (0)
Front & Back Matter (2019) (0)
Front & Back Matter (2020) (0)
300 CHAPTER 10 Posterior Pituitary (2015) (0)
Subject Index Vol. 67, Suppl. 1, 2007 (2007) (0)
Excitatory and inhibitory factors in the control of salt appetite in rats (1994) (0)
Acknowledgement of reviewers 2013 (2014) (0)
A rat model of cerebral salt wasting (2008) (0)
SUN-371 Hyponatremia Correction Normalizes Bone Mineral Density and Bone Fragility in Rats (2020) (0)
PSY4 TRENDS IN HYPONATREMIA MANAGEMENT AND ASSOCIATED OUTCOMES IN HOSPITAL SETTINGS: INTERIM RESULTS FROM AN OBSERVATIONAL, PROSPECTIVE, MULTI-CENTER, GLOBAL REGISTRY IN HOSPITALIZED PATIENTS (2011) (0)
Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats (2012) (0)
Hyponatremia elicits gene expression changes driving osteoclast differentiation and functions (2022) (0)
Front & Back Matter (2019) (0)
exercise-induced hypervolemia in humans Increased renal tubular sodium reabsorption during (2015) (0)
Postsurgical and Posttraumatic Hyponatremia (2022) (0)
Rationale and design of a global hyponatraemia registry (2011) (0)
MON-425 SIADH with Epistaxis: Rule out Esthesioneuroblastoma (2019) (0)
The reply. (2014) (0)
Historical Aspects of Hyponatremia. (2019) (0)
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus (2022) (0)
Front & Back Matter (2019) (0)
Regulation of Renal Aquaporins and Sodium Transporters During Vasopressin-Escape in the Rat (2000) (0)
Central systems in the control of food intake (1994) (0)
Sometimes it's neither the hormones nor the genes (2001) (0)
Front & Back Matter (2020) (0)
Front & Back Matter (2019) (0)
An Unusual Case of Latent Autoimmune Diabetes in Adult and Pancreatic Neuroendocrine Tumor in a Patient Presenting With Diabetes (2021) (0)
Front & Back Matter (2019) (0)
Front & Back Matter (2019) (0)
681 HYPONATREMIA IN HOSPITALIZED PATIENTS WITH CIRRHOSIS: INTERIM DATA FROM AN OBSERVATIONAL, PROSPECTIVE, MULTI-CENTER, GLOBAL HYPONATREMIA REGISTRY INDICATES THAT HYPONATREMIA IS FREQUENTLY NOT TREATED (2012) (0)
Management of hyponatremia in the hospital: interim results from a prospective, observational, multi-center, global registry (2012) (0)
Hyponatraemia and osteoporosis (2019) (0)
Oxytocin and the control of sodium appetite in rats (1989) (0)
Front & Back Matter (2020) (0)
Cholecystokinin and Neuroendocrine Secretion (2020) (0)
menitary-adrenal axis between groups of Marked differences in functioning of the (2015) (0)
Estimates of the relative Disorders of Water Metabolism (2002) (0)
Sex and Age Differences in Renal Ability to Conserve Water and Sodium in F344 x Brown Norway Rats (2006) (0)
Assessment Of Cystic Fibrosis Carrier Status Among Those With Exercise-associated Hyponatremia In A 161-km Ultramarathon: 1950 (2011) (0)
Unexplained hyponatraemia - diagnosis strategies (2004) (0)
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus (2022) (0)
Table 1. [Etiologies of the Various Polyuria-Polydipsia Syndromes]. (2019) (0)
Renomedullary blood flow and blood volume are increased during vasopressin escape (2011) (0)
Vasopressin and Water Balance in Endurance Athletes: 164 (2008) (0)
Front & Back Matter (2020) (0)
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. (2022) (0)
The effect sex chromosomal complement (SCC) on the expression of sodium transporters is dependent on gonadal sex (2009) (0)
300: MANAGEMENT OF HYPONATREMIA IN THE INTENSIVE CARE UNIT (ICU) (2012) (0)
Front & Back Matter (2019) (0)
and acute plasma volume expansion Fluid and electrolyte hormonal responses to exercise (2015) (0)
Exercise-Induced Hyponatremia: An Assessment of the International Hydration Recommendations Followed During the Gran Trail De Peñalara and Vitoria-Gasteiz Ironman Competitions (2022) (0)
Vasopressin is secreted in response to systemic infusion of cholecystokinin but not gastric distension in humans (1989) (0)
Table 3: [Hypertonic Saline Infusion Test (with plasma copeptin measurement)]. (2019) (0)
Pathophysiology, Evaluation, Outcomes, and Treatment of Hyponatremia (2022) (0)
Abstract 2730: Results from the SALT 1 and 2 Trials: Multicenter, Randomized, Placebo-controlled Trials in Patients with Euvolemic and Hypervolemic Hyponatremia (2006) (0)
Front & Back Matter (2020) (0)
Front & Back Matter (2019) (0)
Hyponatremia, sodium metabolism and bone (2014) (0)
Contributors (2012) (0)
Differentiation of Hypotonic Hyponatremia from Other Causes of Hyponatremia (2007) (0)
Evaluation of tolvaptan, an oral vasopressin V2 receptor antagonist, in asymptomatic hyponatremia: effects on sodium concentration and patient reported health outcomes (2007) (0)
Front & Back Matter (2019) (0)
CEV_5997_Conivaptan: evidence supporting its therapeutic use (2009) (0)
Subject Index Vol. 42, 1986 (1986) (0)
Chapter 1 – Clinical Disorders of the Neurohypophysis (1987) (0)
Front & Back Matter (2020) (0)
Brain c-Fos expression in response to altered food intake and central oxytocin administration in rats (1992) (0)
Front & Back Matter (2020) (0)
Front & Back Matter (2019) (0)
Biological bases of sodium appetite in rats (1989) (0)
Front & Back Matter (2019) (0)
Figure 1: [Algorithm for Diagnosis of the Various Types of Polyuria Polydipsia Syndromes]. (2019) (0)
Oxytocin levels in response to pituitary provocation tests in healthy volunteers. (2021) (0)
242 HYPONATREMIA IN HOSPITALIZED PATIENTS WITH CIRRHOSIS: INTERIM DATA FROM AN OBSERVATIONAL, PROSPECTIVE, MULTI-CENTER, GLOBAL HYPONATREMIA REGISTRY (2013) (0)
Simultaneously Recorded Vagal Afferent Activity in Urethane-Anesthetized Rats Gastric Vagal Efferent Inhibition Evoked by Intravenous CRF Is Unrelated to (2009) (0)
Response to the Letter to the Editor From G. Decaux and A. Soupart (2006) (0)
Modulation of vasopressin-V2 receptor signaling and adenylyl cyclase VI with chronic vasopressin exposure in rat kidney (2001) (0)
Impairments in the secretion of oxytocin and vasopressin produced by lesions of nucleus medianus (1984) (0)
Front & Back Matter (2019) (0)
Front & Back Matter (2019) (0)
Does the level of circulating vasopressin modulate atrial natriuretic peptide secretion in response to volume loading (1991) (0)
Measuring CME Outcomes: Assessment of an HFSA Annual Meeting Symposium (2012) (0)
Fluid and Electrolyte Homeostasis: Clinical Disease (2009) (0)
How to manage hyponatraemia according to guidelines? The USA perspective (2015) (0)
Renal Effects of Neurohypophyseal Peptides (2006) (0)
MP02-03 NOCTURNAL URINE SAMPLING AS A PATIENT-CENTERED ALTERNATIVE TO VOIDING DIARIES IN THE DIAGNOSIS OF NOCTURNAL POLYURIA (2020) (0)
Front & Back Matter (2020) (0)
Vasopressin and Disorders of Water Homeostasis (2012) (0)
232 – Posterior Pituitary (2012) (0)
limitations stated by the authors, we suggest that the results of the study, though may be useful, are not ready for prescribing fluid intake guidelines during endurance kayaking. (2008) (0)
Posterior Pituitary (2018) (0)
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus. (2022) (0)
Response to the Letter to the Editor. (2015) (0)
Emergency Management of Acute and Chronic Hyponatremia (2018) (0)
New Developments in Reproductive and Stress Neuroendocrinology (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Joseph George Verbalis?

Joseph George Verbalis is affiliated with the following schools: